GOSS News

GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Clinical Execution Failures: Levi & Korsinsky

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Pinterest, Inc. (PINS), New Era Energy & Digital, Inc. (NUAI), and Gossamer Bio, Inc. (GOSS) Announced by Holzer & Holzer, LLC

Class Action Lawsuit Reminder from Pomerantz LLP for Shareholders of Gossamer Bio, Inc. – GOSS

GOSS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS

DEADLINE ALERT for PINS, NUAI, GOSS, MEDP: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

DEADLINE ALERT for GOSS, NUAI, and MEDP: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

GOSS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 Ready to Announce with Confidence?

Portnoy Law Firm Announces Class Action on Behalf of Gossamer Bio, Inc. Investors

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure – Hagens Berman